Detalhe da pesquisa
1.
Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1+ Myeloid Dendritic Cells.
Int J Mol Sci
; 23(9)2022 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35563257
2.
The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcome.
Eur J Immunol
; 45(12): 3351-61, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26377033
3.
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine.
Theranostics
; 13(15): 5483-5500, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37908728
4.
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade.
Mol Ther Methods Clin Dev
; 22: 172-182, 2021 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34485603
5.
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation.
Biomolecules
; 10(10)2020 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33003481
6.
Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production.
Vaccines (Basel)
; 7(3)2019 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394834
7.
Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent.
Cancers (Basel)
; 11(6)2019 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31234464
8.
Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy.
Theranostics
; 8(13): 3559-3570, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026866
9.
Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation.
Oncotarget
; 9(29): 20476-20489, 2018 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755666
10.
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.
Oncotarget
; 9(45): 27797-27808, 2018 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29963238
11.
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety.
ACS Nano
; 12(10): 9815-9829, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30256609
12.
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers.
Oncotarget
; 8(26): 41932-41946, 2017 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28410210
13.
Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon.
Mol Ther Nucleic Acids
; 5(6): e326, 2016 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27327138
14.
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells.
Cancer Immunol Res
; 4(2): 146-56, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26659303
15.
The ReNAissanCe of mRNA-based cancer therapy.
Expert Rev Vaccines
; 14(2): 235-51, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25263094
16.
Targeting the tumor microenvironment to enhance antitumor immune responses.
Oncotarget
; 6(3): 1359-81, 2015 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682197